Symbiotic Ventures

Early stage venture capital firm

We help founders transform compelling ideas into reality

Area of Focus

01

Early Stage Investments

We specialize in pre-seed, seed, and series A investments.

02

Market Potential

We target opportunities that will capture market share and disrupt industries.

03

Founding Teams

We look for teams with an aligned clear vision, complementary skill sets, and a track record of execution.

04

Scalable Business Model

We look for businesses that can grow rapidly and have a clear path to profitability.

05

Monetization Strategies

We work with companies positioned for long term success through acquisition, IPO, or other means.

06

Portfolio Diversity

We establish an advantaged risk adjusted return by building a diversified portfolio of companies across multiple industries and geographies.

Proven Success in Investment Strategies

We are proud to have a track record of successful outcomes for our founders and LPs.

Symbiotic Ventures was founded and is led by a GP that brings extensive experience in private equity and engineering. He has led the sourcing and execution of acquisitions totaling over $2 billion of aggregated transaction value in the last 4 years. He currently is Managing Partner and head of corporate development at an energy startup that he’s guided from zero revenue and five employees to $4 billion annual revenue and 300 employees. The proven track record exemplifies his ability to identify and create differential value in complex business models while concurrently resolving operational challenges of rapid growth.

See Portfolio

Experienced Team
at Your Service

We strive to partner with market setting founders with the priority of letting builders build, but we have the technical and operational expertise to assist the talented teams at our portfolio companies.

Through its unique advisory base, Symbiotic Ventures offers deep expertise in B2B SaaS, B2C e-commerce, AI, VR, and AR. We focus on investing and applying our expertise in healthcare, fintech, logistics, energy, defense, and real estate.

0

Current Investments

0

Expected Number of Investments (Next 5 Years)

Portfolio

Successful Exits

darwin
darwinai-icon

DarwinAI

Acquired By: Apple Inc.

Exit Date: 03-14-2024

Current Investments

Accern
Agile DD
Agile Devices
Agorum
CERA
EyeCheq
Fluid Biomed
Stiched Insights

★ ★ ★ ★ ★

Symbiotic Ventures provided the capital and expertise we needed to develop our product, grow our team, and gain market traction.

xxx

/

Our Client

Our Team

Employee 1

General Partner

“Founders that have a realistic playbook and market strategy stand out.”

Employee 2

Limited Partner

“Founders that have a realistic playbook and market strategy stand out.”

Employee 3

Limited Partner

“Founders that have a realistic playbook and market strategy stand out.”

Employee 4

Limited Partner

“Founders that have a realistic playbook and market strategy stand out.”

Employee 5

Limited Partner

“Founders that have a realistic playbook and market strategy stand out.”

Frequently Asked Questions

What investment stages does Symbiotic Ventures (SV) target?

We specialize in pre-seed, seed, and series A investments.

Is SV focused on a particular market?

Our primary goal is to invest in innovative companies across a well-diversified set of industries.

I am a investor or a founder – how do I get in touch?

Send us a message using the contact form below. We will follow up and request further information.

We invest in innovative, market disrupting companies.

Contact us using the form below.


Resources

© Copyright Symbiotic Ventures 2024. All rights reserved.